Trump Aid Spending Freeze Halts Leading Malaria Vaccine Programme

Global collaboration with US researchers likely to be set back by years, including on spread of drug-resistant HIV A flagship programme to create malaria vaccines has been halted by the Trump administration, in just one example of a rippling disruption to health research around the globe since the new US president took power. The USAid Malaria Vaccine Development Program which works to prevent child deaths by creating more effective second-generation vaccines funds research by teams collaborating across institutes, including the US university Johns Hopkins and the UKs University of Oxford.